Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis.

MLA

Chang, Claudia V., et al. “Oncogenic Osteomalacia: Loss of Hypophosphatemia Might Be the Key to Avoid Misdiagnosis.” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 56, no. 8, Nov. 2012, pp. 570–73. EBSCOhost, https://doi.org/10.1590/s0004-27302012000800018.

APA

Chang, C. V., Conde, S. J., Luvizotto, R. A. M., Nunes, V. S., Bonates, M. C., Felicio, A. C., Lindsey, S. C., Moraes, F. H., Tagliarini, J. V., Mazeto, G. M. F. S., Kopp, P., & Nogueira, C. R. (2012). Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis. Arquivos Brasileiros de Endocrinologia e Metabologia, 56(8), 570–573. https://doi.org/10.1590/s0004-27302012000800018

Chicago

Chang, Claudia V, Sandro J Conde, Renata A M Luvizotto, Vânia S Nunes, Milla C Bonates, Andre C Felicio, Susan C Lindsey, et al. 2012. “Oncogenic Osteomalacia: Loss of Hypophosphatemia Might Be the Key to Avoid Misdiagnosis.” Arquivos Brasileiros de Endocrinologia e Metabologia 56 (8): 570–73. doi:10.1590/s0004-27302012000800018.